Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program.

ABSTRACT: Involving diverse populations in early-phase (phase I and II) cancer clinical trials is critical to informed therapeutic development. However, given the growing costs and complexities of early-phase trials, trial activation and enrollment barriers may be greatest for these studies at healthcare facilities that provide care to the most diverse patient groups, including those in historically underserved communities (e.g., safety-net healthcare systems). To promote diverse and equitable access to early-phase cancer clinical trials, we are implementing a novel program for the transfer of care to enhance access to early-phase cancer clinical trials. We will then perform a mixed-methods study to determine perceptions and impact of the program. Specifically, we will screen, recruit, and enroll di

SUBMITTER: Nwachukwu C 

PROVIDER: S-EPMC11016932 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature